Human medicines European public assessment report (EPAR): Potactasol, topotecan, Date of authorisation: 06/01/2011, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Potactasol, topotecan, Date of authorisation: 06/01/2011, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Levitra, vardenafil, Date of authorisation: 06/03/2003, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Levitra, vardenafil, Date of authorisation: 06/03/2003, Revision: 34, Status: Authorised

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 14 July 2025, 09:30 (CEST) to 14 July 2025, 13:00 (CEST)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 14 July 2025, 09:30 (CEST) to 14 July 2025, 13:00 (CEST)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 16 September 2025, 09:30 (CEST) to 16 September 2025, 13:00 (CEST)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 16 September 2025, 09:30 (CEST) to 16 September 2025, 13:00 (CEST)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, European Medicines Agency, Amsterdam, the Netherlands, from 14 October 2025 to 15 October 2025

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, European Medicines Agency, Amsterdam, the Netherlands, from 14 October 2025 to 15 October 2025

Annex IV questions and answers – Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Annex IV questions and answers – Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness